EUR 0.87
(-3.89%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.28 EUR | -27.27% |
2022 | -0.22 EUR | -83.33% |
2021 | -0.12 EUR | -236.99% |
2020 | 0.09 EUR | 97.74% |
2019 | 0.04 EUR | -17.5% |
2018 | 0.05 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.04 EUR | 53.78% |
2024 Q2 | -0.05 EUR | -4.09% |
2024 Q3 | -0.05 EUR | -9.17% |
2023 FY | - EUR | -27.27% |
2023 Q4 | -0.10 EUR | 0.0% |
2023 Q1 | -0.04 EUR | 22.33% |
2023 Q3 | -0.10 EUR | -90.4% |
2023 Q2 | -0.05 EUR | -25.0% |
2022 Q3 | -0.05 EUR | 37.12% |
2022 Q4 | -0.05 EUR | 0.0% |
2022 FY | - EUR | -83.33% |
2022 Q2 | -0.08 EUR | -68.52% |
2022 Q1 | -0.05 EUR | 51.16% |
2021 Q4 | -0.10 EUR | -49.18% |
2021 FY | - EUR | -236.99% |
2021 Q3 | -0.07 EUR | -347.04% |
2021 Q2 | 0.03 EUR | -10.0% |
2021 Q1 | 0.03 EUR | -36.58% |
2020 Q3 | 0.02 EUR | 0.0% |
2020 FY | - EUR | 97.74% |
2020 Q4 | 0.05 EUR | 215.33% |
2019 FY | - EUR | -17.5% |
2018 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -0.29 EUR | 3.448% |
Nexstim Plc | -0.20 EUR | -40.0% |
Revenio Group Oyj | 0.72 EUR | 138.889% |